These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 22014429)

  • 1. Breast cancer: can axillary lymph node dissection be avoided?
    Barry M; Kell MR
    Eur J Surg Oncol; 2012 Jan; 38(1):6-7. PubMed ID: 22014429
    [No Abstract]   [Full Text] [Related]  

  • 2. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
    Recht A
    Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micrometastases in sentinel lymph nodes: few data make for hard decisions.
    Rowan K
    J Natl Cancer Inst; 2009 Oct; 101(20):1374-6. PubMed ID: 19797724
    [No Abstract]   [Full Text] [Related]  

  • 5. False negative sentinel node procedure established through palpation of the biopsy wound.
    Tanis PJ; Nieweg OE; Merkus JW; Peterse JL; Kroon BB
    Eur J Surg Oncol; 2000 Nov; 26(7):714-5. PubMed ID: 11078620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
    Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
    Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
    Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sentinel lymph node biopsy and axillary lymph node dissection].
    Noguchi M; Tsugawa K; Miwa K; Taniya T
    Gan To Kagaku Ryoho; 2000 Jul; 27(7):961-6. PubMed ID: 10925679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sentinel lymph node (SLN) in breast cancer: prediction of axillary metastasis confined to the SLN spares patients further axillary dissection].
    Sato K; Hiraide H; Mochizuki H
    Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):445-8. PubMed ID: 11436505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of axillary clearance for patients with sentinel node-positive early breast cancer.
    Benson JR; Wishart GC
    Br J Surg; 2011 Nov; 98(11):1499-500. PubMed ID: 21861266
    [No Abstract]   [Full Text] [Related]  

  • 15. How to handle positive sentinel nodes?
    Schmidt C
    J Natl Cancer Inst; 2010 Dec; 102(24):1820-1, 1823. PubMed ID: 21139099
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micrometastatic sentinel lymph node disease: do patients benefit or suffer harm from axillary lymph node dissection?
    Ziogas D; Zografos GC
    Ann Surg Oncol; 2010 Mar; 17(3):936-7; author reply 938. PubMed ID: 19937389
    [No Abstract]   [Full Text] [Related]  

  • 19. Can axillary lymph node dissection be omitted in patients with breast cancer and positive sentinel nodes?
    Dominici L; Golshan M
    Minerva Chir; 2010 Oct; 65(5):547-54. PubMed ID: 21081866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
    Cserni G
    Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.